Corcept Therapeutics | CORT - Koszty Sprzedaży





Koszty Sprzedaży Zmiana Data
Acadia Pharmaceuticals USD 26.22M 4.58M 2025-12
Alaunos Therapeutics USD 0 18K 2024-09
ANI Pharmaceuticals USD 122.88M 6.86M 2025-12
Ardelyx USD 10.85M 6.87M 2025-12
Assertio Holdings USD 8.89M 2.29M 2024-06
Aurora Cannabis CAD 88.61M 30.53M 2025-12
BioMarin Pharmaceutical USD 161.56M 16.62M 2025-12
Bristol-Myers Squibb USD 4.92B 657M 2025-12
Canopy Growth CAD 53.08M 8.3M 2025-12
Corcept Therapeutics USD 2.54M 2.05M 2025-12
Eli Lilly USD 3.37B 363.7M 2025-12
Esperion Therapeutics USD 27.85M 13.43M 2025-12
J&J USD 7.97B 689M 2025-12
Knight Therapeutics CAD 82.22M 1.03M 2025-12
Lexicon Pharmaceuticals USD 201K 191K 2025-12
Merck USD 3.32B 531M 2025-12
Nektar Therapeutics USD 4.43M 5.3M 2024-09
Novartis USD 3.54B 3M 2025-12
Novartis USD 3.54B 7M 2025-12
Omeros USD 33.16M 18.52M 2024-06
Pacira USD 54.62M 6.02M 2025-12
Pfizer USD 6.29B 2.12B 2025-12
Supernus Pharmaceuticals USD 47.53M 4.24M 2025-12
TG Therapeutics USD 38.14M 10.05M 2025-12